Should You Add C4 Therapeutics Inc (CCCC) Stock to Your Portfolio Monday?

The 2 rating InvestorsObserver gives to C4 Therapeutics Inc (CCCC) stock puts it near the bottom of the Healthcare sector. In addition to scoring higher than 29 percent of stocks in the Healthcare sector, CCCC’s 2 overall rating means the stock scores better than 2 of all stocks.

CCCC has an Overall Score of 2. Find out what this means to you and get the rest of the rankings on CCCC!

See Full CCCC Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 2 means the stock is more attractive than 2 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With C4 Therapeutics Inc Stock Today?

C4 Therapeutics Inc (CCCC) stock is trading at $1.52 as of 2:08 PM on Monday, Oct 30, a rise of $0.13, or 9.35% from the previous closing price of $1.39. The stock has traded between $1.35 and $1.53 so far today. Volume today is less active than usual. So far 240,508 shares have traded compared to average volume of 625,935 shares. Click Here to get the full Stock Report for C4 Therapeutics Inc stock.